Drugs / Tegafur, Gimeracil and Oteracil Potassium Capsules
Tegafur, Gimeracil and Oteracil Potassium Capsules
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05934331 | Jul 2023 → Jul 2026 overdue | digestive system cancer | LaNova Medicines Zhejiang Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tegafur, Gimeracil and Oteracil Potassium Capsules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05934331 ↗ |
| Route | Oral | “Oral Administration” NCT05934331 ↗ |